# Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

> **NCT04253483** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 14 (actual)

## Conditions studied

- Stage I Prostate Cancer AJCC v8
- Stage II Prostate Cancer AJCC v8
- Stage IIA Prostate Cancer AJCC v8
- Stage IIB Prostate Cancer AJCC v8
- Stage IIC Prostate Cancer AJCC v8

## Interventions

- **RADIATION:** High-Dose Rate Brachytherapy
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Stereotactic Ablative Radiotherapy

## Key facts

- **NCT ID:** NCT04253483
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-17
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04253483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04253483, "Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04253483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*